MHRA announces a new notification scheme for low risk clinical trials
Articles filtered by tag
Draft EMA Reflection Paper on Artificial Intelligence
EMA considerations on the use of AI in the medicinal product lifecycle.
MHRA announces a new notification scheme for low risk clinical trials
EMA considerations on the use of AI in the medicinal product lifecycle.